Cost effectiveness

Videos

Understanding the Medicare Database Evidence on dHACM Cost-Effectiveness Research

08/30/2022

Martha R. Kelso, RN, HBOT

Martha R. Kelso, RN, HBOT, touches on the extent of the evidence supporting a study on the cost-effectiveness of dHACM allografts in lower extremity diabetic ulcers.

Martha R. Kelso, RN, HBOT,...

08/30/2022

Wounds

Videos

Discussing the Cost-Effectiveness of dHACM Allografts in Lower Extremity Diabetic Ulcers

08/30/2022

Martha R. Kelso, RN, HBOT

Martha R. Kelso, RN, HBOT, speaks on a recent study looking at cost-effectivness as related to dehydrated human amnion/chorion membrane allografts.

Martha R. Kelso, RN, HBOT,...

08/30/2022

Wounds

Fish skin grafts* are a cost effective treatment option for diabetic foot ulcers

Standard treatment of chronic diabetic foot ulcers (DFU) is expensive and, for more than half of DFU patients, unsuccessful1. Health care policy decision makers should seek the most effec...

08/19/2021

News

Comparison of Costs, Outcomes Among Neoadjuvant-Adjuvant Treatment Strategies for Breast Cancer

12/08/2020

Journal of Clinical Pathways

Conference Coverage

Polatuzumab Vedotin Plus Bendamustine-Rituximab Cost-Effective for DLBCL

12/05/2020

Journal of Clinical Pathways

New, Longer 220 mm Length of Lutonix 035 Drug-Coated Balloon Reduces Cost at Arkansas Heart Hospital

11/27/2018

Cath Lab Digest talks with Ian M. Cawich, MD, Arkansas Heart Hospital, Little Rock, Arkansas.

Cath Lab Digest talks with Ian M. Caw...

The newest device that we have been able to use has been the 220 mm length version of the Lutonix 035 drug-coated balloon (BD/Bard). We have used this product since it launched in August and have done six cases thus far, all with great...

The newest device that we have...

11/27/2018

Cath Lab Digest

Cath Lab Management

Optimizing Your Cath Lab Activity Levels: Seven Deadly Sins in Cath Lab Operations Management

08/01/2017

Maartje E. Zonderland, PhD – Managing Consultant,
Integrated Health Solutions, Medtronic, Heerlen, Netherlands

Maartje E. Zonderland, PhD – Managing...

This article describes seven deadly sins related to cath lab operations management. Many cath labs globally suffer from most of these sins. For a medium-sized cath lab with four procedure rooms, the yearly potential loss is equivalent to...

This article describes seven...

08/01/2017

Cath Lab Digest

Interview

Improving Access to Quality Cancer Care Close to Home

12/13/2016

JCP Editors

Patients with cancer are often forced to choose between seeking specialized medical treatment at facilities located a significant distance from their homes or accepting less rigorous care at local treatment centers....

...

12/13/2016

Journal of Clinical Pathways

Your Path to Success: Expert Advice

Pushing the Limits on Same-Day Discharge: The Value Proposition of Same-Day Discharge in Patients Undergoing Complex PCI

11/03/2016

Amit P. Amin MD, MSc^1,2,3, Brandon Rahn, MHA², Samantha Miller, RN, BSN², Mary L. Caruso, RN², and Patricia Crimmins-Reda, RN, BSN^2,3

Amit P. Amin MD, MSc1,2,3, Brandon Ra...

In our ongoing effort to bring greater visibility and understanding to the growing economic opportunities transradial can afford when coupled with same-day discharge, we are pleased to introduce Dr. Amin’s original article. His article hits...

In our ongoing effort to bring...

11/03/2016

Cath Lab Digest

The Use of Tirofiban in ACS Patients

10/07/2016

Cath Lab Digest talks with:

Emmanouil S. Brilakis, MD, PhD, University of Texas Southwestern Medical Center, Dallas, Texas; Veterans Affairs North Texas Health Care System, Dallas, Texas; Minneapolis Heart Institute, Minneapolis, Minnesota.

Martin Zenni, MD, Associate Professor, Department of Medicine, Division of Cardiology, Medical Director, Cardiovascular Off Campus Outreach Program; Medical Director of Nuclear Cardiology, University of Florida Health Shands, Jacksonville, Florida.

Cath Lab Digest talks with: Emmanoui...

A new, more concentrated format of tirofiban will soon become available to deliver the FDA-approved, high-dose bolus of 25 mcg/kg at the start of treatment: pre-mixed, ready-to-use, 250 mcg/mL in a 15 mL vial.

A new, more concentrated format...

10/07/2016

Cath Lab Digest